Moderna and Pfizer-BioNTech are in a tight race to launch their COVID-19 vaccines in Europe after both applied for emergency EU approval on Tuesday, though there was uncertainty over whether a rollout ...
Getting a COVID booster could save your life, even if you’ve had multiple prior infections and vaccinations. A study, ...
Covid vaccine boosters continue to protect against serious illness and death, especially for people ages 65 and older, ...
Pfizer Inc "didn't conspire with anyone" to delay release of efficacy results for the COVID-19 vaccine it developed with German partner BioNTech SE until after the U.S. presidential election, Chief ...
A study showed updated COVID-19 vaccines reduced severe outcomes, like hospitalizations and deaths among U.S. veterans.
MET-097i’s mid-stage performance “bodes well” for Pfizer’s proposed buyout of Metsera, according to BMO Capital Markets, a ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced detailed results from two pivotal studies that make up the ELEVATE UC Phase 3 registrational program evaluating etrasimod, a ...
JERUSALEM (Reuters) – Pfizer’s COVID-19 vaccine greatly reduces virus transmission, two Israeli studies have found, shedding light on one of the biggest questions of the global effort to quash the ...
Pfizer (PFE), a pharmaceutical and biotechnology company, rose to great heights during the pandemic with its COVID-19 vaccine. However, it has spent the last few years attempting to reposition itself ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback